Impact of prothrombin time-International Normalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion

被引:8
|
作者
Isbizuka, Mitsuru [1 ]
Tago, Kazuma [1 ]
Kubota, Keilichi [1 ]
机构
[1] Dokkyo Med Univ, Dept Surg Gastroenterol, Mibu, Tochigi 3210293, Japan
关键词
DISSEMINATED INTRAVASCULAR COAGULATION; IMMOBILIZED FIBER COLUMN; CONTINUOUS VENOVENOUS HEMOFILTRATION; SEVERE SEPSIS; PROTEASE INHIBITOR; ANTITHROMBIN-III; COMPLICATION; MANAGEMENT; SURVIVAL; EFFICACY;
D O I
10.1016/j.surg.2014.03.009
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Although most patients with septic shock have a poor outcome, some may survive after blood purification treatment such as polymyxin B cartridge hemoperfusion (PMX). Objective. To explore the most significant characteristic associated with 28-day mortality in patients with septic shock receiving PMX. Methods. Between April 2006 and March 2008, 116 patients with septic shock who had received PMX in a prospectively collected multicenter collaborative study were enrolled. Uni- and multivariate analyses Wing the Cox proportional hazard model were performed to assess the most significant clinical characteristic that was associated with 28-day mortality. Results. Among 33 clinicolaboratory characteristics, receiver operating characteristic (ROC) curve analyses Selected 12 characteristics with recommended cutoff values such as HCO3- (<= 19.81/>19.8; mEq/L), base excess (<=-5.35/>-5.35; mEq/L), diastolic blood pressure (<= 48/>48 mmHg), mean arterial pressure (<= 73/>73 mmHg), pH (<= 7.29/>7.29), interleukin-6 (<= 19,150/>19,150 pg/dL), prothrombin time International Normalized Ratio (PT-INR; <= 2.05/>2.05), predictive value of Acute Physiology and Chronic Health Evaluation II (APACHE II; <= 0.4/>0.4), pyruvate (<= 1.82/>1.82 mg/dL),. APACHE II score (<= 21/>21), acetate/pyruvate ratio (<= 19/>19), and acetate (<= 44.8/>44.8 mg/dL) on the basis of large area under the ROC curves for 28-day mortality. The results of uni- and multivariate analyses using these selected characteristics revealed that only PT-INR (<= 2.05/>2.05; hazard ratio, 2.823; 95% CI, 1.243-6.412; P = .013) was associated with 28-day mortality. Survival curve analysis demonstrated a significant difference in 28-day mortality between patients with lower (<= 2.05) and higher (>2.05) PT-INR (P < .001). Conclusion. Prolonged PT-INR is an independent risk factor for 28-day mortality in patients receiving PMX for septic shock.
引用
收藏
页码:168 / 175
页数:8
相关论文
共 50 条
  • [1] Exacerbation of prothrombin time-international normalized ratio before second polymyxin B cartridge hemoperfusion predicts poor outcome of patients with severe sepsis and/or septic shock
    Ishizuka, Mitsuru
    Terasaki, Azusa
    Kubota, Keiichi
    JOURNAL OF SURGICAL RESEARCH, 2016, 200 (01) : 308 - 314
  • [2] Impact of prothrombin time International Noimalized Ratio on outcome of patients with septic shock receiving polymyxin B cartridge hemoperfusion (vol 156, pg 168, 2014)
    Ishizuka, Mitsuru
    Tago, Kazuma
    Kubota, Keiichi
    SURGERY, 2015, 157 (02) : 408 - 408
  • [3] Time to Initiation of Treatment with Polymyxin B Cartridge Hemoperfusion in Septic Shock Patients
    Takeyama, Naoshi
    Noguchi, Hiroshi
    Hirakawa, Akihiko
    Kano, Hideki
    Morino, Kazuma
    Obata, Toru
    Sakamoto, Tetsuya
    Tamai, Fumihiro
    Ishikura, Hiroyasu
    Kase, Youichi
    Kobayashi, Makoto
    Naka, Toshio
    Takahash, Yoshiki
    BLOOD PURIFICATION, 2012, 33 (04) : 252 - 256
  • [4] Effects of Tramadol Coadministration on Prothrombin Time-International Normalized Ratio in Patients Receiving Warfarin
    Hosono, Tomomi
    Kondo, Aiko
    Kambayashi, Yasuyuki
    Homma, Masato
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2017, 137 (08): : 999 - 1003
  • [5] Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban
    Chao, Tze-Fan
    Chan, Yi-Hsin
    Tsai, Pei-Chien
    Lee, Hsin-Fu
    Chang, Shang-Hung
    Kuo, Chi-Tai
    Lip, Gregory Y. H.
    Chen, Shih-Ann
    Yeh, Yung-Hsin
    BIOMEDICINES, 2022, 10 (12)
  • [6] Effect of polymyxin B hemoperfusion on the outcome of patients with sepsis and septic shock
    Lin, Wei-Ting
    Lai, Chih-Cheng
    Wang, Jian-Jhong
    Chao, Chien-Ming
    JOURNAL OF INFECTION, 2020, 80 (03) : 364 - 365
  • [8] Kinetic-pharmacodynamic model of warfarin for prothrombin time-international normalized ratio in Japanese patients
    Hirai, Toshinori
    Aoyama, Takahiko
    Tsuji, Yasuhiro
    Itoh, Toshimasa
    Matsumoto, Yoshiaki
    Iwamoto, Takuya
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (03) : 828 - 836
  • [9] Diagnostic and Prognostic Significance of the Prothrombin Time/International Normalized Ratio in Sepsis and Septic Shock
    Schupp, Tobias
    Weidner, Kathrin
    Rusnak, Jonas
    Jawhar, Schanas
    Forner, Jan
    Dulatahu, Floriana
    Brueck, Lea Marie
    Hoffmann, Ursula
    Bertsch, Thomas
    Mueller, Julian
    Weiss, Christel
    Akin, Ibrahim
    Behnes, Michael
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [10] Diagnostic and Prognostic Significance of the Prothrombin Time/International Normalized Ratio in Sepsis and Septic Shock
    Schupp, Tobias
    Weidner, Kathrin
    Rusnak, Jonas
    Jawhar, Schanas
    Forner, Jan
    Dulatahu, Floriana
    Brueck, Lea Marie
    Hoffmann, Ursula
    Bertsch, Thomas
    Mueller, Julian
    Weiss, Christel
    Akin, Ibrahim
    Behnes, Michael
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28